As of Apr 24
| -0.16 / -4.92%|
The 1 analysts offering 12-month price forecasts for Rock Creek Pharmaceuticals Inc have a median target of 50.00, with a high estimate of 50.00 and a low estimate of 50.00. The median estimate represents a +1,518.12% increase from the last price of 3.09.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.